Rutendo Kamudzandu, NP
Gerontology · Independence, MONPI 1699195602
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 24.1% of the total. Reporting peaked in 2024 at $1,707 and has fallen 78.6% since, to $365 in 2025. Among gerontology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$577
- Lilly USA, LLC$351
- Novo Nordisk$319
- GSK$307
- Pfizer$271
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,542100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 78 | $1,094 |
| AstraZeneca | 25 | $577 |
| Lilly USA, LLC | 21 | $351 |
| Novo Nordisk | 24 | $319 |
| GSK | 17 | $307 |
| Pfizer | 19 | $271 |
| Tris Pharma Inc | 2 | $243 |
| Teva Pharmaceuticals USA, Inc. | 2 | $233 |
| Abbott | 12 | $197 |
| Johnson & Johnson | 7 | $113 |
| Boehringer Ingelheim | 7 | $111 |
| Astellas Pharma US Inc | 4 | $74 |
| Merck | 4 | $72 |
| Bayer | 4 | $57 |
| Mylan Specialty L.p. | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| Boston Scientific | 1 | $43 |
| Exact Sciences | 3 | $41 |
| Dynavax Technologies Corporation | 3 | $40 |
| Novartis | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Amgen | 2 | $29 |
| Neurelis, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Corium, LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Endogastric Solutions, Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$243
- Quillivant$243
- Quillichew ER$243
- Austedo XR$233
- TRELEGY ELLIPTA$114
How this compares
$4,542 in reported general payments places this provider in the 90th percentile of 175 gerontology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 91 | $90,919 |
| EliquisApixaban | 49 | $52,032 |
| OzempicSemaglutide | 38 | $39,440 |
| TrulicityDulaglutide | 28 | $34,659 |
| XareltoRivaroxaban | 25 | $26,863 |
| JanuviaSitagliptin Phosphate | 23 | $23,711 |
| LinzessLinaclotide | 14 | $17,751 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $13,615 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $7,498 |
| VascepaIcosapent Ethyl | 14 | $7,027 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,605 |
| Omeprazole | 286 | $5,318 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 39 | $4,974 |
| Gabapentin | 236 | $4,947 |
| Atorvastatin Calcium | 547 | $4,426 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $111 | $90,91991 claims |
| PfizerEliquis, Abrysvo, Paxlovid | $271 | $57,61175 claims |
| Novo NordiskOzempic | $319 | $39,44038 claims |
| Lilly USA, LLCTrulicity | $351 | $34,65928 claims |
| Johnson & JohnsonXarelto | $113 | $26,86325 claims |
| MerckJanuvia | $72 | $23,71123 claims |
| AbbVieLinzess, Synthroid | $1,094 | $21,03965 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $307 | $19,22027 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 175 gerontology providers in Missouri.
Other gerontology in Independence
- Peter SamoeiIndependence$4K
- Michele DuckettIndependence$2K
- Tonia NeriniBevier$29K
- Melissa DusenberryKansas City$8K
- Kelly DaltonSpringfield$8K
- Laura TullisKansas City$7K
- Marissa SaengsamranSaint Louis$6K
- Matthew RobertsBridgeton$6K
- Amy GuanSaint Louis$5K
- Kayla WeissSaint Louis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.